Global Vaccine for Influenza Market Research Report 2023

Report ID: 2005766 | Published Date: Sep 2024 | No. of Page: 89 | Base Year: 2023 | Rating: 4.6 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Vaccine for Influenza Market Overview
    1.1 Product Overview and Scope of Vaccine for Influenza
    1.2 Vaccine for Influenza Segment by Type
        1.2.1 Global Vaccine for Influenza Sales Growth Rate Comparison by Type (2022-2028)
        1.2.2 Trivalent Influenza Vaccine
        1.2.3 Quadrivalent Influenza Vaccine
    1.3 Vaccine for Influenza Segment by Application
        1.3.1 Global Vaccine for Influenza Sales Comparison by Application: (2022-2028)
        1.3.2 For Children (6 months to 3 years)
        1.3.3 For Adults and Children over 3 years
    1.4 Global Vaccine for Influenza Market Size Estimates and Forecasts
        1.4.1 Global Vaccine for Influenza Revenue 2017-2028
        1.4.2 Global Vaccine for Influenza Sales 2017-2028
        1.4.3 Vaccine for Influenza Market Size by Region: 2017 Versus 2021 Versus 2028
2 Vaccine for Influenza Market Competition by Manufacturers
    2.1 Global Vaccine for Influenza Sales Market Share by Manufacturers (2017-2022)
    2.2 Global Vaccine for Influenza Revenue Market Share by Manufacturers (2017-2022)
    2.3 Global Vaccine for Influenza Average Price by Manufacturers (2017-2022)
    2.4 Manufacturers Vaccine for Influenza Manufacturing Sites, Area Served, Product Type
    2.5 Vaccine for Influenza Market Competitive Situation and Trends
        2.5.1 Vaccine for Influenza Market Concentration Rate
        2.5.2 The Global Top 5 and Top 10 Largest Vaccine for Influenza Players Market Share by Revenue
        2.5.3 Global Vaccine for Influenza Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
    2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Vaccine for Influenza Retrospective Market Scenario by Region
    3.1 Global Vaccine for Influenza Retrospective Market Scenario in Sales by Region: 2017-2022
    3.2 Global Vaccine for Influenza Retrospective Market Scenario in Revenue by Region: 2017-2022
    3.3 North America Vaccine for Influenza Market Facts & Figures by Country
        3.3.1 North America Vaccine for Influenza Sales by Country
        3.3.2 North America Vaccine for Influenza Revenue by Country
        3.3.3 U.S.
        3.3.4 Canada
    3.4 Europe Vaccine for Influenza Market Facts & Figures by Country
        3.4.1 Europe Vaccine for Influenza Sales by Country
        3.4.2 Europe Vaccine for Influenza Revenue by Country
        3.4.3 Germany
        3.4.4 France
        3.4.5 U.K.
        3.4.6 Italy
        3.4.7 Russia
    3.5 Asia Pacific Vaccine for Influenza Market Facts & Figures by Region
        3.5.1 Asia Pacific Vaccine for Influenza Sales by Region
        3.5.2 Asia Pacific Vaccine for Influenza Revenue by Region
        3.5.3 China
        3.5.4 Japan
        3.5.5 South Korea
        3.5.6 India
        3.5.7 Australia
        3.5.8 China Taiwan
        3.5.9 Indonesia
        3.5.10 Thailand
        3.5.11 Malaysia
    3.6 Latin America Vaccine for Influenza Market Facts & Figures by Country
        3.6.1 Latin America Vaccine for Influenza Sales by Country
        3.6.2 Latin America Vaccine for Influenza Revenue by Country
        3.6.3 Mexico
        3.6.4 Brazil
        3.6.5 Argentina
    3.7 Middle East and Africa Vaccine for Influenza Market Facts & Figures by Country
        3.7.1 Middle East and Africa Vaccine for Influenza Sales by Country
        3.7.2 Middle East and Africa Vaccine for Influenza Revenue by Country
        3.7.3 Turkey
        3.7.4 Saudi Arabia
        3.7.5 UAE
4 Global Vaccine for Influenza Historic Market Analysis by Type
    4.1 Global Vaccine for Influenza Sales Market Share by Type (2017-2022)
    4.2 Global Vaccine for Influenza Revenue Market Share by Type (2017-2022)
    4.3 Global Vaccine for Influenza Price by Type (2017-2022)
5 Global Vaccine for Influenza Historic Market Analysis by Application
    5.1 Global Vaccine for Influenza Sales Market Share by Application (2017-2022)
    5.2 Global Vaccine for Influenza Revenue Market Share by Application (2017-2022)
    5.3 Global Vaccine for Influenza Price by Application (2017-2022)
6 Key Companies Profiled
    6.1 Sanofi
        6.1.1 Sanofi Corporation Information
        6.1.2 Sanofi Description and Business Overview
        6.1.3 Sanofi Vaccine for Influenza Sales, Revenue and Gross Margin (2017-2022)
        6.1.4 Sanofi Vaccine for Influenza Product Portfolio
        6.1.5 Sanofi Recent Developments/Updates
    6.2 CSL
        6.2.1 CSL Corporation Information
        6.2.2 CSL Description and Business Overview
        6.2.3 CSL Vaccine for Influenza Sales, Revenue and Gross Margin (2017-2022)
        6.2.4 CSL Vaccine for Influenza Product Portfolio
        6.2.5 CSL Recent Developments/Updates
    6.3 GSK
        6.3.1 GSK Corporation Information
        6.3.2 GSK Description and Business Overview
        6.3.3 GSK Vaccine for Influenza Sales, Revenue and Gross Margin (2017-2022)
        6.3.4 GSK Vaccine for Influenza Product Portfolio
        6.3.5 GSK Recent Developments/Updates
    6.4 Mylan
        6.4.1 Mylan Corporation Information
        6.4.2 Mylan Description and Business Overview
        6.4.3 Mylan Vaccine for Influenza Sales, Revenue and Gross Margin (2017-2022)
        6.4.4 Mylan Vaccine for Influenza Product Portfolio
        6.4.5 Mylan Recent Developments/Updates
    6.5 Hulan Bio
        6.5.1 Hulan Bio Corporation Information
        6.5.2 Hulan Bio Description and Business Overview
        6.5.3 Hulan Bio Vaccine for Influenza Sales, Revenue and Gross Margin (2017-2022)
        6.5.4 Hulan Bio Vaccine for Influenza Product Portfolio
        6.5.5 Hulan Bio Recent Developments/Updates
    6.6 AstraZeneca
        6.6.1 AstraZeneca Corporation Information
        6.6.2 AstraZeneca Description and Business Overview
        6.6.3 AstraZeneca Vaccine for Influenza Sales, Revenue and Gross Margin (2017-2022)
        6.6.4 AstraZeneca Vaccine for Influenza Product Portfolio
        6.6.5 AstraZeneca Recent Developments/Updates
    6.7 CCBIO
        6.6.1 CCBIO Corporation Information
        6.6.2 CCBIO Description and Business Overview
        6.6.3 CCBIO Vaccine for Influenza Sales, Revenue and Gross Margin (2017-2022)
        6.4.4 CCBIO Vaccine for Influenza Product Portfolio
        6.7.5 CCBIO Recent Developments/Updates
7 Vaccine for Influenza Manufacturing Cost Analysis
    7.1 Vaccine for Influenza Key Raw Materials Analysis
       7.1.1 Key Raw Materials
       7.1.2 Key Suppliers of Raw Materials
    7.2 Proportion of Manufacturing Cost Structure
    7.3 Manufacturing Process Analysis of Vaccine for Influenza
    7.4 Vaccine for Influenza Industrial Chain Analysis
8 Marketing Channel, Distributors and Customers
    8.1 Marketing Channel
    8.2 Vaccine for Influenza Distributors List
    8.3 Vaccine for Influenza Customers
9 Vaccine for Influenza Market Dynamics
    9.1 Vaccine for Influenza Industry Trends
    9.2 Vaccine for Influenza Market Drivers
    9.3 Vaccine for Influenza Market Challenges
    9.4 Vaccine for Influenza Market Restraints
10 Global Market Forecast
    10.1 Vaccine for Influenza Market Estimates and Projections by Type
        10.1.1 Global Forecasted Sales of Vaccine for Influenza by Type (2023-2028)
        10.1.2 Global Forecasted Revenue of Vaccine for Influenza by Type (2023-2028)
    10.2 Vaccine for Influenza Market Estimates and Projections by Application
        10.2.1 Global Forecasted Sales of Vaccine for Influenza by Application (2023-2028)
        10.2.2 Global Forecasted Revenue of Vaccine for Influenza by Application (2023-2028)
    10.3 Vaccine for Influenza Market Estimates and Projections by Region
        10.3.1 Global Forecasted Sales of Vaccine for Influenza by Region (2023-2028)
        10.3.2 Global Forecasted Revenue of Vaccine for Influenza by Region (2023-2028)
11 Research Finding and Conclusion
12 Methodology and Data Source
    12.1 Methodology/Research Approach
        12.1.1 Research Programs/Design
        12.1.2 Market Size Estimation
        12.1.3 Market Breakdown and Data Triangulation
    12.2 Data Source
        12.2.1 Secondary Sources
        12.2.2 Primary Sources
    12.3 Author List
    12.4 Disclaimer

List of Tables
    Table 1. Global Vaccine for Influenza Sales Growth Rate Comparison by Type (2022-2028) & (K Units) & (US$ Million)
    Table 2. Global Vaccine for Influenza Sales Growth Rate Comparison by Application (2022-2028) & (K Units) & (US$ Million)
    Table 3. Global Vaccine for Influenza Market Size by Region (US$ Million) (2017 VS 2021 VS 2028)
    Table 4. Global Vaccine for Influenza Market Competitive Situation by Manufacturers in 2021
    Table 5. Global Vaccine for Influenza Sales (K Units) of Key Manufacturers (2017-2022)
    Table 6. Global Vaccine for Influenza Sales Market Share by Manufacturers (2017-2022)
    Table 7. Global Vaccine for Influenza Revenue (US$ Million) by Manufacturers (2017-2022)
    Table 8. Global Vaccine for Influenza Revenue Share by Manufacturers (2017-2022)
    Table 9. Global Market Vaccine for Influenza Average Price (US$/Unit) of Key Manufacturers (2017-2022)
    Table 10. Manufacturers Vaccine for Influenza Manufacturing Sites and Area Served
    Table 11. Manufacturers Vaccine for Influenza Product Type
    Table 12. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 13. Global Vaccine for Influenza by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Vaccine for Influenza as of 2021)
    Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
    Table 15. Global Vaccine for Influenza Sales by Region (2017-2022) & (K Units)
    Table 16. Global Vaccine for Influenza Sales Market Share by Region (2017-2022)
    Table 17. Global Vaccine for Influenza Revenue by Region (2017-2022) & (US$ Million)
    Table 18. Global Vaccine for Influenza Revenue Market Share by Region (2017-2022)
    Table 19. North America Vaccine for Influenza Sales by Country (2017-2022) & (K Units)
    Table 20. North America Vaccine for Influenza Sales Market Share by Country (2017-2022)
    Table 21. North America Vaccine for Influenza Revenue by Country (2017-2022) & (US$ Million)
    Table 22. North America Vaccine for Influenza Revenue Market Share by Country (2017-2022)
    Table 23. Europe Vaccine for Influenza Sales by Country (2017-2022) & (K Units)
    Table 24. Europe Vaccine for Influenza Sales Market Share by Country (2017-2022)
    Table 25. Europe Vaccine for Influenza Revenue by Country (2017-2022) & (US$ Million)
    Table 26. Europe Vaccine for Influenza Revenue Market Share by Country (2017-2022)
    Table 27. Asia Pacific Vaccine for Influenza Sales by Region (2017-2022) & (K Units)
    Table 28. Asia Pacific Vaccine for Influenza Sales Market Share by Region (2017-2022)
    Table 29. Asia Pacific Vaccine for Influenza Revenue by Region (2017-2022) & (US$ Million)
    Table 30. Asia Pacific Vaccine for Influenza Revenue Market Share by Region (2017-2022)
    Table 31. Latin America Vaccine for Influenza Sales by Country (2017-2022) & (K Units)
    Table 32. Latin America Vaccine for Influenza Sales Market Share by Country (2017-2022)
    Table 33. Latin America Vaccine for Influenza Revenue by Country (2017-2022) & (US$ Million)
    Table 34. Latin America Vaccine for Influenza Revenue Market Share by Country (2017-2022)
    Table 35. Middle East and Africa Vaccine for Influenza Sales by Country (2017-2022) & (K Units)
    Table 36. Middle East and Africa Vaccine for Influenza Sales Market Share by Country (2017-2022)
    Table 37. Middle East and Africa Vaccine for Influenza Revenue by Country (2017-2022) & (US$ Million)
    Table 38. Middle East and Africa Vaccine for Influenza Revenue Market Share by Country (2017-2022)
    Table 39. Global Vaccine for Influenza Sales by Type (2017-2022) & (K Units)
    Table 40. Global Vaccine for Influenza Sales Market Share by Type (2017-2022)
    Table 41. Global Vaccine for Influenza Revenue by Type (2017-2022) & (US$ Million)
    Table 42. Global Vaccine for Influenza Revenue Share by Type (2017-2022)
    Table 43. Global Vaccine for Influenza Price by Type (2017-2022) & (US$/Unit)
    Table 44. Global Vaccine for Influenza Sales (K Units) by Application (2017-2022)
    Table 45. Global Vaccine for Influenza Sales Market Share by Application (2017-2022)
    Table 46. Global Vaccine for Influenza Revenue by Application (2017-2022) & (US$ Million)
    Table 47. Global Vaccine for Influenza Revenue Share by Application (2017-2022)
    Table 48. Global Vaccine for Influenza Price by Application (2017-2022) & (US$/Unit)
    Table 49. Sanofi Corporation Information
    Table 50. Sanofi Description and Business Overview
    Table 51. Sanofi Vaccine for Influenza Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 52. Sanofi Vaccine for Influenza Product
    Table 53. Sanofi Recent Developments/Updates
    Table 54. CSL Corporation Information
    Table 55. CSL Description and Business Overview
    Table 56. CSL Vaccine for Influenza Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 57. CSL Vaccine for Influenza Product
    Table 58. CSL Recent Developments/Updates
    Table 59. GSK Corporation Information
    Table 60. GSK Description and Business Overview
    Table 61. GSK Vaccine for Influenza Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 62. GSK Vaccine for Influenza Product
    Table 63. GSK Recent Developments/Updates
    Table 64. Mylan Corporation Information
    Table 65. Mylan Description and Business Overview
    Table 66. Mylan Vaccine for Influenza Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 67. Mylan Vaccine for Influenza Product
    Table 68. Mylan Recent Developments/Updates
    Table 69. Hulan Bio Corporation Information
    Table 70. Hulan Bio Description and Business Overview
    Table 71. Hulan Bio Vaccine for Influenza Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 72. Hulan Bio Vaccine for Influenza Product
    Table 73. Hulan Bio Recent Developments/Updates
    Table 74. AstraZeneca Corporation Information
    Table 75. AstraZeneca Description and Business Overview
    Table 76. AstraZeneca Vaccine for Influenza Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 77. AstraZeneca Vaccine for Influenza Product
    Table 78. AstraZeneca Recent Developments/Updates
    Table 79. CCBIO Corporation Information
    Table 80. CCBIO Description and Business Overview
    Table 81. CCBIO Vaccine for Influenza Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 82. CCBIO Vaccine for Influenza Product
    Table 83. CCBIO Recent Developments/Updates
    Table 84. Production Base and Market Concentration Rate of Raw Material
    Table 85. Key Suppliers of Raw Materials
    Table 86. Vaccine for Influenza Distributors List
    Table 87. Vaccine for Influenza Customers List
    Table 88. Vaccine for Influenza Market Trends
    Table 89. Vaccine for Influenza Market Drivers
    Table 90. Vaccine for Influenza Market Challenges
    Table 91. Vaccine for Influenza Market Restraints
    Table 92. Global Vaccine for Influenza Sales Forecast by Type (2023-2028) & (K Units)
    Table 93. Global Vaccine for Influenza Sales Market Share Forecast by Type (2023-2028)
    Table 94. Global Vaccine for Influenza Revenue Forecast by Type (2023-2028) & (US$ Million)
    Table 95. Global Vaccine for Influenza Revenue Market Share Forecast by Type (2023-2028)
    Table 96. Global Vaccine for Influenza Sales Forecast by Application (2023-2028) & (K Units)
    Table 97. Global Vaccine for Influenza Sales Market Share Forecast by Application (2023-2028)
    Table 98. Global Vaccine for Influenza Revenue Forecast by Application (2023-2028) & (US$ Million)
    Table 99. Global Vaccine for Influenza Revenue Market Share Forecast by Application (2023-2028)
    Table 100. Global Vaccine for Influenza Sales Forecast by Region (2023-2028) & (K Units)
    Table 101. Global Vaccine for Influenza Sales Market Share Forecast by Region (2023-2028)
    Table 102. Global Vaccine for Influenza Revenue Forecast by Region (2023-2028) & (US$ Million)
    Table 103. Global Vaccine for Influenza Revenue Market Share Forecast by Region (2023-2028)
    Table 104. Research Programs/Design for This Report
    Table 105. Key Data Information from Secondary Sources
    Table 106. Key Data Information from Primary Sources
List of Figures
    Figure 1. Product Picture of Vaccine for Influenza
    Figure 2. Global Vaccine for Influenza Market Share by Type in 2021 & 2028
    Figure 3. Trivalent Influenza Vaccine Product Picture
    Figure 4. Quadrivalent Influenza Vaccine Product Picture
    Figure 5. Global Vaccine for Influenza Market Share by Application in 2021 & 2028
    Figure 6. For Children (6 months to 3 years)
    Figure 7. For Adults and Children over 3 years
    Figure 8. Global Vaccine for Influenza Revenue, (US$ Million), 2017 VS 2021 VS 2028
    Figure 9. Global Vaccine for Influenza Market Size (2017-2028) & (US$ Million)
    Figure 10. Global Vaccine for Influenza Sales (2017-2028) & (K Units)
    Figure 11. Vaccine for Influenza Sales Share by Manufacturers in 2021
    Figure 12. Global Vaccine for Influenza Revenue Share by Manufacturers in 2021
    Figure 13. The Global 5 and 10 Largest Vaccine for Influenza Players: Market Share by Revenue in 2021
    Figure 14. Vaccine for Influenza Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2017 VS 2021
    Figure 15. Global Vaccine for Influenza Sales Market Share by Region (2017-2022)
    Figure 16. Global Vaccine for Influenza Sales Market Share by Region in 2021
    Figure 17. Global Vaccine for Influenza Revenue Market Share by Region (2017-2022)
    Figure 18. Global Vaccine for Influenza Revenue Market Share by Region in 2021
    Figure 19. U.S. Vaccine for Influenza Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 20. Canada Vaccine for Influenza Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 21. Germany Vaccine for Influenza Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 22. France Vaccine for Influenza Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 23. U.K. Vaccine for Influenza Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 24. Italy Vaccine for Influenza Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 25. Russia Vaccine for Influenza Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 26. China Vaccine for Influenza Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 27. Japan Vaccine for Influenza Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 28. South Korea Vaccine for Influenza Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 29. India Vaccine for Influenza Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 30. Australia Vaccine for Influenza Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 31. China Taiwan Vaccine for Influenza Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 32. Indonesia Vaccine for Influenza Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 33. Thailand Vaccine for Influenza Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 34. Malaysia Vaccine for Influenza Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 35. Mexico Vaccine for Influenza Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 36. Brazil Vaccine for Influenza Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 37. Argentina Vaccine for Influenza Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 38. Turkey Vaccine for Influenza Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 39. Saudi Arabia Vaccine for Influenza Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 40. UAE Vaccine for Influenza Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 41. Sales Market Share of Vaccine for Influenza by Type (2017-2022)
    Figure 42. Manufacturing Cost Structure of Vaccine for Influenza
    Figure 43. Manufacturing Process Analysis of Vaccine for Influenza
    Figure 44. Vaccine for Influenza Industrial Chain Analysis
    Figure 45. Channels of Distribution
    Figure 46. Distributors Profiles
    Figure 47. Bottom-up and Top-down Approaches for This Report
    Figure 48. Data Triangulation
    Figure 49. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Sanofi
CSL
GSK
Mylan
Hulan Bio
AstraZeneca
CCBIO
Frequently Asked Questions
Vaccine for Influenza report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Vaccine for Influenza report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Vaccine for Influenza report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports

Drugs for Oncology

Drugs for Oncology market is segmented by players, region (country), by Type and by Application.  ... Read More

Media for Stem Cell

The research report includes specific segments by region (country), by company, by Type and by Ap ... Read More

Animal Logistics

Animal Logistics market is segmented by players, region (country), by Type and by Application. Pl ... Read More